Panax notoginseng extract doubles the hemolysis function
-
Last Update: 2016-04-18
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Cardiovascular and cerebrovascular diseases are not only the killer of human health, but also the main cause of "overwork death" of young people However, cardiovascular and cerebrovascular diseases are caused by "junk blood" characterized by hyperlipidemia, which leads to "Scaling" and "blockage" of blood vessels It can be said that it is the necessary way to prevent and treat cardiovascular and cerebrovascular diseases by dissolving thrombus in blood vessels, removing rubbish in blood and unblocking blood circulation Panax notoginseng has been widely recognized as a good medicine for the prevention and treatment of cardiovascular and cerebrovascular diseases The hemolysis experiment and a large number of clinical applications of Cui Panax notoginseng have strongly confirmed this point However, the current situation is that a large number of Panax notoginseng applications are limited to such rough processing as slicing and powdering Not only a lot of precious 37 resources are wasted, but also the effect is low The hemolytic effect of PNS extracted with high purity by modern biotechnology can be increased more than ten times, which is why Cui Sanqi often said that "Sanqi is still that Sanqi, but its effect has been greatly different" The Patent Office of the people's Republic of China has granted the patent for PNS extraction technology, which affirms the function of PNS extraction: "it has the obvious function of expanding cerebral blood vessels, increasing cerebral blood flow, antithrombotic and anticoagulant effects, can achieve the real purpose of lowering blood fat, can clear away free radicals and other harmful substances, inhibit platelet aggregation, and reduce body consumption Oxygen, can play a comprehensive and systematic role in reducing blood lipid, and has a good effect on the prevention and treatment of hyperlipidemia "
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.